Murugaiah A M S, Wallinder Chalotta, Mahalingam A K, Wu Xiongyu, Wan Yiqian, Plouffe Bianca, Botros Milad, Karlén Anders, Hallberg Mathias, Gallo-Payet Nicole, Alterman Mathias
Department of Medicinal Chemistry, BMC, Uppsala University, PO Box 574, SE-751 23 Uppsala, Sweden.
Bioorg Med Chem. 2007 Nov 15;15(22):7166-83. doi: 10.1016/j.bmc.2007.07.026. Epub 2007 Aug 22.
A versatile parallel synthetic method to obtain three series of non-cyclic analogues of the first drug-like selective angiotensin II AT(2) receptor agonist (1) has been developed. In analogy with the transformation of losartan to valsartan it was demonstrated that a non-cyclic moiety could be employed as an imidazole replacement to obtain AT(2) selective compounds. In all the three series, AT(2) receptor ligands with affinities in the lower nanomolar range were found. None of the analogues exhibited any affinity for the AT(1) receptor. Four compounds, 17, 22, 39 and 51, were examined in a neurite outgrowth cell assay. All four compounds were found to exert a high agonistic effect as deduced from their capacity to induce neurite elongation in neuronal cells, as does angiotensin II.
已开发出一种通用的平行合成方法,用于获得第一代类药物选择性血管紧张素II AT(2)受体激动剂(1)的三个系列的非环状类似物。与氯沙坦向缬沙坦的转化类似,已证明非环状部分可用作咪唑替代物以获得AT(2)选择性化合物。在所有这三个系列中,均发现了亲和力处于低纳摩尔范围的AT(2)受体配体。没有一种类似物对AT(1)受体表现出任何亲和力。在神经突生长细胞试验中检测了四种化合物,即17、22、39和51。正如血管紧张素II一样,从它们在神经元细胞中诱导神经突伸长的能力推断,所有这四种化合物都具有很高的激动作用。